It will be awarding a contract for a company to conduct a series of laboratory tests on AOAC International analysis methods.
“The main objective of the contract will be to provide the ODS, NIH, and its stakeholders with accurate, reliable, practical, validated, and published chemical analysis methods for selected dietary supplements as directed by the ODS and informed by the AOAC process,” ODS states.
A request for proposal will be available on June 8. ODS says that the number and types of validation studies performed will “depend on available resources, public health priorities, and the AOAC committee’s recommended priorities.”
ODS notes that the creation of official methods of analysis are necessary for dietary supplement study and legal and regulatory purposes, as well as to create a consensus of standards to be used in international trade.
Nutritional Outlook thanks Harry Rice for the tip.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.